Financhill
Back

Phreesia Quote, Financials, Valuation and Earnings

Phreesia Price Quote

$25.15
-0.01 (5.5%)
(Updated: December 21, 2024 at 5:41 AM ET)

Phreesia Key Stats

Buy
56
Phreesia (PHR) is a Buy

Day range:
$23.18 - $25.63
52-week range:
$17.07 - $29.16
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.54
P/B ratio:
5.74%

Volume:
749.2K
Avg. volume:
473.9K
1-year change:
15.41%
Market cap:
$1.5B
Revenue:
$356.3M
EPS:
$-1.47

How Much Does Phreesia Make?

Data Unavailable

Is Phreesia Growing As A Company?

Data Unavailable

Phreesia Stock Price Performance

  • Did Phreesia Stock Go Up Last Month?
    Phreesia share price went up by 35.85% last month
  • Did PHR's Share Price Rise Over The Last Year?
    PHR share price rose by 15.41% over the past 1 year

What Is Phreesia 52-Week High & Low?

  • What Is Phreesia’s 52-Week High Share Price?
    Phreesia has traded as high as $29.16 over the past 52 weeks
  • What Is Phreesia’s 52-Week Low Share Price?
    Phreesia has traded as low as $17.07 over the past 52 weeks

Phreesia Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Phreesia?

Data Unavailable

Is Phreesia Cash Flow Positive?

Data Unavailable

Phreesia Return On Invested Capital

Data Unavailable

Phreesia Earnings Date & Stock Price

  • What Is Phreesia's Stock Price Today?
    A single share of PHR can be purchased today for 25.16
  • What Is Phreesia’s Stock Symbol?
    Phreesia trades on the nyse under the ticker symbol: PHR
  • When Is Phreesia’s Next Earnings Date?
    The next quarterly earnings date for Phreesia is scheduled on March 14, 2025
  • When Is PHR's next ex-dividend date?
    Phreesia's next ex-dividend date is December 22, 2024
  • How To Buy Phreesia Stock?
    You can buy Phreesia shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Phreesia Competitors

  • Who Are Phreesia's Competitors?
    Below is a list of companies who compete with Phreesia or are related in some way:
    • American Shared Hospital Services (AMS)
    • Astrana Health Inc (ASTH)
    • Biote Corp (BTMD)
    • Cryo-Cell International Inc (CCEL)
    • P3 Health Partners Inc (PIII)

Phreesia Dividend Yield

Data Unavailable

Phreesia Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 221.37%
Revenue: 16.57% 0.45%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 30.21
Upside from Last Price: 20.09%

Major Shareholders

Data Unavailable